CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemia.
Saved in:
| Title: | CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemia. |
|---|---|
| Authors: | Prajapati SC; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Meydan C; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA., Neelamraju Y; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Wang Z; Department of Genome Sciences, University of Virginia, Charlottesville, VA, USA., Fan H; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Dunham N; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Dillon R; King's College London, London, United Kingdom., Gandara JA; Department of Physiology, Biophysics and Systems Biology, Weill Cornell Medicine, New York, NY, USA., Lee T; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Sheridan C; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Zumbo P; Department of Physiology, Biophysics and Systems Biology, Weill Cornell Medicine, New York, NY, USA., Becker MW; Department of Medicine, University of Rochester, Rochester, NY, USA., Bullinger L; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine Berlin, Berlin, Germany., Carroll MP; University of Pennsylvania Perelman School of Medicine, Division of Hematology and Oncology, Pennsylvania, PA, USA., D'Andrea RJ; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia., Levine RL; Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mason C; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.; Department of Physiology, Biophysics and Systems Biology, Weill Cornell Medicine, New York, NY, USA.; The World Quant Initiative for Quantitative Prediction, Weill Cornell Medicine, New York, USA., Melnick AM; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Zang C; Department of Genome Sciences, University of Virginia, Charlottesville, VA, USA., Bekiranov S; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Garrett-Bakelman FE; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, University of Virginia, Charlottesville, VA, USA.; UVA Comprehensive Cancer Center, Charlottesville, VA, USA. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2025 Aug 27. Date of Electronic Publication: 2025 Aug 27. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
